Literature DB >> 3805762

Mouse skin damage caused by cytolysin from Vibrio vulnificus and by V. vulnificus infection.

L D Gray, A S Kreger.   

Abstract

Light and electron microscopy of mouse skin damage caused by intradermal infection with a virulent strain of Vibrio vulnificus and by a single intradermal injection of the cytolytic toxin produced by the bacterium revealed similar structural alterations. The epidermis was intact; however, the infection and toxin produced acute cellulitis characterized by extensive extracellular edema; disorganization of collagen bundles; large accumulations of cell debris and plasma proteins; damaged or necrotic fat cells, capillary endothelial cells, and muscle cells; and mild inflammatory cell infiltration. The virulent strain of V. vulnificus produced a capsule and was resistant to phagocytosis in vivo, whereas a weakly virulent strain of the bacterium did not produce a capsule and was readily phagocytized and digested. Factors that may be important in the pathogenesis of V. vulnificus wound infections include a capsule that inhibits phagocytosis and an extracellular cytolytic toxin that is responsible, at least in part, for the severe tissue damage characteristic of such wound infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3805762     DOI: 10.1093/infdis/155.2.236

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Pulmonary damage by Vibrio vulnificus cytolysin.

Authors:  J W Park; S N Ma; E S Song; C H Song; M R Chae; B H Park; R W Rho; S D Park; H R Kim
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 3.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

4.  Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.

Authors:  A M Starks; T R Schoeb; M L Tamplin; S Parveen; T J Doyle; P E Bomeisl; G M Escudero; P A Gulig
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates.

Authors:  M L Tamplin; J K Jackson; C Buchrieser; R L Murphree; K M Portier; V Gangar; L G Miller; C W Kaspar
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

6.  Toxic and enzymatic activities of Vibrio vulnificus biotype 2 with respect to host specificity.

Authors:  E G Biosca; C Amaro
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

Review 7.  Winner of the Theodore E. Woodward Clinical Award. Monster of the Chesapeake Bay--Vibrio vulnificus.

Authors:  F M Calia
Journal:  Trans Am Clin Climatol Assoc       Date:  1995

8.  Identification of OmpU of Vibrio vulnificus as a fibronectin-binding protein and its role in bacterial pathogenesis.

Authors:  Sung Young Goo; Hyun-Ju Lee; Woo Hwang Kim; Kyu-Lee Han; Dae-Kyun Park; Hyun-Jung Lee; Sung Min Kim; Kun-Soo Kim; Kyu-Ho Lee; Soon-Jung Park
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

9.  A calcium-calmodulin antagonist blocks experimental Vibrio vulnificus cytolysin-induced lethality in an experimental mouse model.

Authors:  Young-Rae Lee; Kwang-Hyun Park; Zhao-Zhen Lin; Young-Jong Kho; Jin-Woo Park; Hye-Won Rho; Bon-Sun Koo; Hyung-Rho Kim; Eun-Kyung Song; Hong-Nu Yu; Myung-Kwan Han; Seung-Ok Lee; Eun-Chung Jhee; Jong-Suk Kim
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.

Authors:  A C Wright; J G Morris
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.